| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.00096 | 1 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.00099 | 1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.00079 | 1 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.00084 | 1 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.00075 | 1 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.00063 | 1 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.00062 | 1 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00056 | 1 |